Arkolith/Insider Trading/SRNE/Form 4

Janda Kim

DirectorSorrento Therapeutics, Inc. (SRNE) · full profile →Form 4 · filed Dec 27, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 27, 2021Option exercise(M)3K$4.00$12K6K
Dec 27, 2021Sell(S)3K$5.88$18K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 27, 2021Option exercise(M)3K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-071311) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML